Replication of the association of gene variant near ATM and response to metformin

Pharmacogenomics

Volumn 13, Issue 12, 2012, Pages 1331-1332

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; HEMOGLOBIN A1C; METFORMIN;

ATM GENE; COHORT ANALYSIS; DRUG RESPONSE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84866331214     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.12.115     Document Type: Note

References (13)

1. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycaemia in Type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55(6), 1577-1596 (2012).
2. Zolk O. Disposition of metformin: variability due to polymorphisms of organic cation transporters. Ann. Med. 44, 119-129 (2012).
3. Becker ML, Visser LE, van Schaijk RH et al. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J. 9, 242-247 (2009).
4. Becker ML, Visser LV, van Schaijk RH et al. Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. Diabetes 58, 745-749 (2009).
5. Choi JH, Yee SW, Ramirez AH et al. A common 5-UTR variant in MATE2-K is associated with poor response to metformin. Clin. Pharm. Ther. 90(5), 674-684 (2011).
6. GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group; Wellcome Trust Case Control Consortium 2; Zhou K, Bellenguez C, Spencer CC et al. Common variants near ATM are associated with glycemic response to metformin in Type 2 diabetes. Nat. Genet. 43(2), 117-120 (2011).
7. van Leeuwen N, Nijpels G, Becker ML et al. A gene variant near ATM is significantly associatedd with metformin treatment response in Type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia 55, 1971-1977 (2012).
8. Schalch DS, McFarlin DE, Barlow MH. An unusual form of diabetes mellitus in ataxia telangiectasia. N. Engl. J. Med. 282, 1396-1402 (1970).
9. Boder E. Ataxia telangiectasia: an overview. Kroc Found. Ser. 19, 1-63 (1985).
10. Libby G et al. New users of metformin are at low risk of incident cancer: a cohort study among people with Type 2 diabetes. Diabetes Care 32, 1620-1625 (2009).
11. Sun Y, Connors K, Yang DQ. AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner. Mol. Cell. Biochem. 306, 239-245 (2007).
12. Yee SW, Chen L, Giacomini K. The role of ATM in response to metformin treatment and activation of AMPK. Nat. Genet. 44(4), 359-360 (2012).
13. Leiper JM, Carling D. The role of ATM in response to metformin treatment and activation of AMPK. Nat. Genet. 44(4), 360-361 (2012).